CSX To Rally 20%? Here Are 5 Other Price Target Changes For Monday

Raymond James raised CSX Corporation CSX price target from $31 to $33. Raymond James analyst Patrick Tyler Brown maintained the stock with an Outperform rating. CSX shares rose 1.7% to close at $27.54 on Friday.
Keybanc cut the price target on Match Group, Inc. MTCH from $82 to $74. Keybanc analyst Justin Patterson maintained an Overweight rating on the stock. Match Group shares fell 0.5% to $42.77 in pre-market trading.
BMO Capital lowered Green Plains Inc. GPRE price target from $45 to $31. BMO Capital analyst Kenneth Zaslow downgraded the stock from Outperform to Market Perform. Green Plains shares rose 5.2% to close at $29.02 on Friday.
Piper Sandler cut NovoCure Limited NVCR price target from $90 to $70. Piper Sandler analyst Jason Bednar downgraded the stock from Overweight to Neutral. NovoCure fell 1.5% to $71.55 in pre-market trading.
Barclays cut Analog Devices, Inc. ADI price target from $180 to $140. Barclays analyst Blayne Curtis downgraded the stock from Overweight to Equal-Weight. Analog Devices shares fell 1.6% to $144.29 in pre-market trading.
HC Wainwright & Co cut Talaris Therapeutics, Inc. TALS price target from $18 to $12. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating on the stock. Talaris Therapeutics shares fell 2.8% to $1.38 in pre-market trading.